"Glimmer of hope": A Tasmanian devil colony displays possible immunity to deadly facial tumor disease

Join Our Community of Science Lovers!

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American


Nearly 70 percent of the world's Tasmanian devils (Sarcophilus harrisii) have been killed in the past 10 years by an infectious cancer called devil facial tumor disease (DFTD). So far, no cure has been found, and the disease has spread to almost every corner of the remote island off the southeastern coast of Australia, the only place on Earth where they live in the wild.

But now a colony of devils living near Cradle Mountain in northwestern Tasmania has displayed immunity against DFTD, and scientists say this could be the hope the species needs.

The northwestern population, says lead researcher Katherine Belov of the University of Sydney, is genetically distinct from the eastern devils. So far, the former have not contracted DFTD.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


"We think these devils may be able to see the cancer cells as foreign and mount an immune response against them," Belov said when announcing the research that found the disease-free population.

The research was published March 10 in the journal, Proceedings of the Royal Society B: Biological Sciences.

Belov and her team have found that, in general, Tasmanian devils do not display a broad genetic diversity, and that in terms of immunity most devils are essentially "clones" of each other. But this northwestern population shows enough genetic differentiation that they might be able to resist the disease.

Belov was quick to caution that this genetic distinction does not guarantee permanent immunity, as DFTD has started to evolve, but she called her team's findings a "glimmer of hope" in the fight against the disease.

This isn't the first time that a Tasmanian devil has displayed immunity to DFTD. For several months in 2008 a seemingly immune devil named Cedric was hailed as the possible savior of his species, but he eventually contracted the cancer. That sad discovery did have a silver lining: Cedric's life was saved by surgery, the first time DFTD had been treated in that way.

Previously on ScientificAmerican.com, "Genetic analysis reveals parasitic origin of contagious cancer devastating Tasmanian devils"

Image: Tasmanian devil afflicted with devil facial tumor disease, viaWikimedia Commons

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe